Opiant Pharmaceuticals, Inc. (OPNT)

$20.65

0.00 (0.00%)
Rating:
Recommendation:
Buy
Symbol OPNT
Price $20.65
Beta 0.832
Volume Avg. 0.07M
Market Cap 108.798M
Shares () -
52 Week Range 7.34-27.36
1y Target Est -
DCF Unlevered OPNT DCF ->
DCF Levered OPNT LDCF ->
ROE -114.95% Strong Sell
ROA -81.62% Strong Sell
Operating Margin -
Debt / Equity 80.55% Buy
P/E -3.16 Strong Sell
P/B 5.18 Strong Buy
Annual
Quarter

Earnings

Consensus EPS

Upgrades & Downgrades

Latest OPNT news


Dr. Roger Crystal M.D.
Healthcare
Biotechnology
NASDAQ Capital Market

Opiant Pharmaceuticals, Inc., a specialty pharmaceutical company, develops medicines for addictions and drug overdose. The company offers NARCAN nasal spray, a treatment to reverse opioid overdoses. Its pipeline of product candidates includes medicines for the treatment for opioid overdose reversal; alcohol use disorders; acute cannabinoid overdose; and opioid use disorders. The company was formerly known as Lightlake Therapeutics Inc. and changed its name to Opiant Pharmaceuticals, Inc. in January 2016. Opiant Pharmaceuticals, Inc. was incorporated in 2005 and is headquartered in Santa Monica, California.